PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-03-30

Date Title Company
30-Mar-2022 MediClin AG: Group sales and Group operating result in the second year of Corona above previous year - cautious outlook for year 2022 MediClin AG
30-Mar-2022 Tower Cold Chain launches KTEvolution container for pharmaceutical transport Tower Cold Chain
30-Mar-2022 London Ambulance Service donates 10 ambulances filled with medical supplies to help people of Ukraine London Ambulance Service (LAS)
30-Mar-2022 Immutep’s efti in combination with MSD’s pembrolizumab shows encouraging antitumor activity in difficult to treat second line metastatic lung cancer patients Immutep Limited
30-Mar-2022 SABINA programme demonstrates SABA reliever overuse is a global issue in asthma management AstraZeneca
30-Mar-2022 EUROPE’S LARGEST COMMERCIAL LAB BUILDING TO BE BUILT AT CANARY WHARF, LONDON, AS FIRST PHASE OF WORLD LEADING HEALTH AND LIFE SCIENCES CLUSTER Canary Wharf Group
30-Mar-2022 Scenic Biotech and the Barth Syndrome Foundation Announce Partnership to Explore Genetic Modifiers to a Find Tailored Treatment for the Complex Rare Disease Scenic Biotech BV
30-Mar-2022 Invizius Awarded Major Biomedical Catalyst Grant to bring Anti-Inflammatory Haemodialysis Treatment to The Clinic Invizius Limited
30-Mar-2022 atai Life Sciences Announces Fourth Quarter and Full Year 2021 Financial Results, Reports on R&D Progress and Highlights Strategic Focus Areas of its Innovative Mental Health Platform atai Life Sciences
30-Mar-2022 Samsung Biologics holds 11th Annual General Meeting of Shareholders Samsung Biologics
30-Mar-2022 Availability of the Q1 2022 Memorandum for modelling purposes Sanofi
30-Mar-2022 CureVac and GSK Start Clinical Development of Second-Generation COVID-19 Vaccine Candidate, CV2CoV CureVac
30-Mar-2022 LTO Network Becomes the World's Premier Blockchain Network for eClinical Applications Through the Partnership of Triall With Crucial Data Solutions Newswire
30-Mar-2022 New analysis shows that Kesimpta®▼ (ofatumumab)-treated adults with relapsing remitting multiple sclerosis (RRMS) are not at increased risk of severe COVID-19 infections Novartis
30-Mar-2022 M1 Kliniken AG publishes preliminary figures for financial year 2021: revenue rises to € 315 million; pre-tax profit amounts to € 14.4 million M1 Kliniken AG
30-Mar-2022 Grünenthal achieves record 2021 results with double-digit growth and major investments in portfolio and pipeline Grünenthal GmbH
30-Mar-2022 HAEMATO AG - preliminary figures for the 2021 financial year: Renewed increase in sales and strong rise in earnings after disproportionate growth of the new Lifestyle and Aesthetics business unit HAEMATO AG
30-Mar-2022 PAION AG ANNOUNCES CHANGE IN MANAGEMENT BOARD PAION AG
30-Mar-2022 Niacin and Niacinamide Market are estimated to garner roughly US$ 1,500 Mn revenues by 2026 MARKITWIRED
30-Mar-2022 Coagulation Analysers Market is projected to reach a value of US$ 1,514 Million at the end of the year 2027 MARKITWIRED